|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.25 SEK | -0.97% |
|
+0.49% | +15.69% |
Vimab Group AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 342.35 million compared to SEK 227.29 million a year ago. Revenue was SEK 347.82 million compared to SEK 229.25 million a year ago.
Net loss was SEK 4.26 million compared to SEK 34.22 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.69% | 20.88M | |
| +6.13% | 7.41B | |
| -32.64% | 3.24B | |
| +5.82% | 2.66B | |
| +11.38% | 1.75B | |
| -9.32% | 1.08B | |
| +31.69% | 907M | |
| -7.64% | 714M | |
| -3.60% | 606M | |
| -8.30% | 539M |
VIMAB GROUP AB 
